CN119072322A - 用于预防或治疗近视的方法及组合物 - Google Patents

用于预防或治疗近视的方法及组合物 Download PDF

Info

Publication number
CN119072322A
CN119072322A CN202380035831.XA CN202380035831A CN119072322A CN 119072322 A CN119072322 A CN 119072322A CN 202380035831 A CN202380035831 A CN 202380035831A CN 119072322 A CN119072322 A CN 119072322A
Authority
CN
China
Prior art keywords
lactic acid
myopia
acid bacteria
choroidal
choroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202380035831.XA
Other languages
English (en)
Chinese (zh)
Inventor
坪田一男
栗原俊英
池田真一
侯靖
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tsubota Laboratory Inc
Original Assignee
Tsubota Laboratory Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tsubota Laboratory Inc filed Critical Tsubota Laboratory Inc
Publication of CN119072322A publication Critical patent/CN119072322A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/18—Peptides; Protein hydrolysates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/05—Dipeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/20—Interleukins [IL]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/165—Paracasei

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Ophthalmology & Optometry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CN202380035831.XA 2022-04-26 2023-04-25 用于预防或治疗近视的方法及组合物 Pending CN119072322A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2022072596 2022-04-26
JP2022-072596 2022-04-26
PCT/JP2023/016344 WO2023210657A1 (ja) 2022-04-26 2023-04-25 近視を予防または治療するための方法および組成物

Publications (1)

Publication Number Publication Date
CN119072322A true CN119072322A (zh) 2024-12-03

Family

ID=88519036

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202380035831.XA Pending CN119072322A (zh) 2022-04-26 2023-04-25 用于预防或治疗近视的方法及组合物

Country Status (9)

Country Link
EP (1) EP4516305A4 (https=)
JP (3) JP7713267B2 (https=)
KR (1) KR20250006145A (https=)
CN (1) CN119072322A (https=)
AU (1) AU2023258808A1 (https=)
CA (1) CA3249939A1 (https=)
MX (1) MX2024013133A (https=)
TW (1) TW202400198A (https=)
WO (1) WO2023210657A1 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2025089394A1 (ja) * 2023-10-25 2025-05-01 株式会社坪田ラボ 近視を予防または治療するための方法および組成物
JP7781461B2 (ja) 2023-10-25 2025-12-08 株式会社坪田ラボ 近視を予防または治療するための方法および組成物
WO2025192737A1 (ja) * 2024-03-15 2025-09-18 株式会社坪田ラボ 脈絡膜菲薄化抑制剤

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3066561B2 (ja) * 1993-10-07 2000-07-17 武田薬品工業株式会社 近視予防・治療剤
TWI658828B (zh) * 2014-10-31 2019-05-11 中國醫藥大學 用於舒緩及減輕近視之醫藥組合物及其製備方法與用途
JP6640803B2 (ja) * 2016-09-09 2020-02-05 キリンホールディングス株式会社 眼疲労の抑制又は改善用組成物
WO2018164113A1 (ja) * 2017-03-06 2018-09-13 学校法人 慶應義塾 マウス近視誘導モデル及び近視予防・抑制のための小胞体ストレス抑制剤
CN107372821A (zh) * 2017-07-25 2017-11-24 芜湖职业技术学院 护眼保健酸奶及其制备方法
CN116568314A (zh) * 2020-09-23 2023-08-08 Pbl生物实验室 新型乳酸菌及其用途
JP7394737B2 (ja) 2020-10-30 2023-12-08 愛三工業株式会社 燃料供給装置
CN112493318A (zh) * 2020-12-01 2021-03-16 河北三元食品有限公司 一种专用于三周岁以上儿童的全营养奶粉及其制备方法
CN113349257A (zh) * 2021-04-13 2021-09-07 石家庄君乐宝乳业有限公司 一种有益于视力保护的发酵乳及其制备方法

Also Published As

Publication number Publication date
MX2024013133A (es) 2024-12-06
JP7808901B2 (ja) 2026-01-30
KR20250006145A (ko) 2025-01-10
JPWO2023210657A1 (https=) 2023-11-02
JP2025129384A (ja) 2025-09-04
EP4516305A4 (en) 2026-04-08
WO2023210657A1 (ja) 2023-11-02
EP4516305A1 (en) 2025-03-05
CA3249939A1 (en) 2025-06-17
JP7713267B2 (ja) 2025-07-25
AU2023258808A1 (en) 2024-11-07
JP2026063064A (ja) 2026-04-10
TW202400198A (zh) 2024-01-01

Similar Documents

Publication Publication Date Title
CN119072322A (zh) 用于预防或治疗近视的方法及组合物
KR102138834B1 (ko) 락토바실러스 가세리 kbl697 균주 및 그 용도
KR102492773B1 (ko) 염증성 질환을 치료하기 위한 조성물 및 방법 및 프로바이오틱 조성물
RS57138B1 (sr) Kompozicije koje sadrže bakterijske sojeve
US20220000951A1 (en) Lactobacillus Crispatus KBL693 Strain and Use Thereof
KR101778734B1 (ko) 비피도박테리움 롱검 kacc 91563으로부터 분리된 esbp 및 이를 이용한 항알레르기 조성물
Abdelazez et al. Verification of Lactobacillus brevis tolerance to simulated gastric juice and the potential effects of postbiotic gamma-aminobutyric acid in streptozotocin-induced diabetic mice
TW202038978A (zh) 包含細菌菌株之組成物
US20250145674A1 (en) Novel Protein, and Therapeutic and Cosmetic Uses Thereof
US20210052678A1 (en) Postbiotic-based composition for the modulation of immune system activation and protection of mucosal barriers
JP2020162479A (ja) 目の不調を改善する組成物及びその利用
JP2021508462A (ja) セルピン産生
CN116004472A (zh) 一株缓解肥胖的丁酸梭菌及其应用
KR100909998B1 (ko) 아라자임을 유효성분으로 하는 유방암 예방 및 치료용약학적 조성물
KR20220102891A (ko) 락토바실러스 존스니 jnu3402 균주 및 이를 포함하는 식품
HK40112500A (zh) 用於预防或治疗近视的方法及组合物
KR102260116B1 (ko) 항균 펩타이드 회피 유전자를 포함하는 재조합 바실러스 칼메트-게렝균의 방광암 항암 치료용 약학적 조성물
KR101504912B1 (ko) 인슐린 저항성 개선 효능을 가지는 락토바실러스 애시도필러스 hy7037 및 이를 유효성분으로 함유하는 제품
US20120003205A1 (en) Pharmaceutical composition containing arazyme for the prevention of liver dysfunction
JP7725011B1 (ja) Ｃｄ４－ｃｄ８－ｔ細胞を増殖および／または活性化させるための組成物
JP7835954B2 (ja) 乳酸菌及び免疫賦活剤
WO2025089394A1 (ja) 近視を予防または治療するための方法および組成物
JP2010158216A (ja) 免疫調節作用を有する乳酸菌
US20210008125A1 (en) Hafnia alvei impact on regulation of appetite and metabolic syndrome aspects
KR20250023259A (ko) 근육 감소 억제 효과를 갖는 갈색거저리 유충 단백 가수분해 펩타이드 조성물

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40112500

Country of ref document: HK

SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination